Literature DB >> 19414571

Emergence of quinolone-resistant Bordetella pertussis in Japan.

Masayuki Ohtsuka1, Ken Kikuchi, Kenichiro Shimizu, Namiko Takahashi, Yuka Ono, Takashi Sasaki, Keiichi Hiramatsu.   

Abstract

Six Bordetella pertussis strains isolated from children in Japan from 2004 to 2006 showed high-level resistance to nalidixic acid (NAL; MIC, >256 microg/ml) and decreased susceptibilities to fluoroquinolones. All of the NAL-resistant strains had the same D87G mutation in gyrA.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19414571      PMCID： PMC2704657          DOI： 10.1128/AAC.00023-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  21 in total

1.  Antimicrobial susceptibility testing of clinical isolates of Bordetella pertussis from northern California: report from the SENTRY Antimicrobial Surveillance Program.

Authors:  K A Gordon; J Fusco; D J Biedenbach; M A Pfaller; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

2.  In vitro activity of fluoroquinolones against erythromycin-susceptible and -resistant Bordetella pertussis.

Authors:  Nadege Bourgeois; Jean-Claude Ghnassia; Florence Doucet-Populaire
Journal:  J Antimicrob Chemother       Date:  2003-03       Impact factor: 5.790

3.  In vitro activity of gemifloxacin and other antimicrobial agents against isolates of Bordetella pertussis and Bordetella parapertussis.

Authors:  J E Mortensen; G L Rodgers
Journal:  J Antimicrob Chemother       Date:  2000-04       Impact factor: 5.790

4.  Susceptibility of Bordetella pertussis to five quinolone antimicrobic drugs.

Authors:  M E Appleman; T L Hadfield; J K Gaines; R E Winn
Journal:  Diagn Microbiol Infect Dis       Date:  1987-10       Impact factor: 2.803

5.  Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli.

Authors:  H Yoshida; M Bogaki; M Nakamura; S Nakamura
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

6.  A simplified method for testing Bordetella pertussis for resistance to erythromycin and other antimicrobial agents.

Authors:  B C Hill; C N Baker; F C Tenover
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

7.  Susceptibility of Bordetella pertussis to doxycycline, cinoxacin, nalidixic acid, norfloxacin, imipenem, mecillinam and rifampicin.

Authors:  G Zackrisson; J E Brorson; B Björnegård; B Trollfors
Journal:  J Antimicrob Chemother       Date:  1985-05       Impact factor: 5.790

8.  Bordetella pertussis isolates with a heterogeneous phenotype for erythromycin resistance.

Authors:  K E Wilson; P K Cassiday; T Popovic; G N Sanden
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

Review 9.  Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection.

Authors:  Joaquim Ruiz
Journal:  J Antimicrob Chemother       Date:  2003-04-14       Impact factor: 5.790

Review 10.  What is new in pertussis?

Authors:  Ellen S Bamberger; Isaac Srugo
Journal:  Eur J Pediatr       Date:  2007-08-01       Impact factor: 3.183
View more
  4 in total

1.  Clinical evaluation of a new rapid immunochromatographic test for detection of Bordetella pertussis antigen.

Authors:  Kenji Okada; Yuho Horikoshi; Naoko Nishimura; Shigeki Ishii; Hiroko Nogami; Chikako Motomura; Isao Miyairi; Naoki Tsumura; Toshihiko Mori; Kenta Ito; Shinichi Honma; Kensuke Nagai; Hiroshi Tanaka; Toru Hayakawa; Chiharu Abe; Kazunobu Ouchi
Journal:  Sci Rep       Date:  2022-05-16       Impact factor: 4.996

2.  The First Macrolide-Resistant Bordetella pertussis Strains Isolated From Iranian Patients.

Authors:  Fereshteh Shahcheraghi; Masoumeh Nakhost Lotfi; Vajiheh Sadat Nikbin; Fahimeh Shooraj; Reza Azizian; Masoumeh Parzadeh; Mohammad Reza Allahyar Torkaman; Seyed Mohsen Zahraei
Journal:  Jundishapur J Microbiol       Date:  2014-06-01       Impact factor: 0.747

3.  Characterization of two Achromobacter xylosoxidans isolates from patients with pertussis-like symptoms.

Authors:  Fiorella Orellana-Peralta; Michelle Jacinto; Maria J Pons; Cláudia Gomes; Carlos Bada; Isabel Reyes; Juana Del Valle Mendoza; Joaquim Ruiz
Journal:  Asian Pac J Trop Med       Date:  2015-06-25       Impact factor: 1.226

4.  Rapid and simple SNP genotyping for Bordetella pertussis epidemic strain MT27 based on a multiplexed single-base extension assay.

Authors:  Kazunari Kamachi; Shu-Man Yao; Chuen-Sheue Chiang; Kentaro Koide; Nao Otsuka; Keigo Shibayama
Journal:  Sci Rep       Date:  2021-03-01       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.